This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AstraZenecas EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases. EsoBiotecs allogeneic cell therapies are made by the in vivo reprogramming of a patients immune cells. The post AstraZeneca Aims to Make Cell Therapy More Accessible With $425M EsoBiotec Acquisition appeared first on MedCity News.
Breaking Into Medical Sales: Gina Torres’s Journey from Nurse to Industry Expert In this inspiring episode, Gina Torres, a seasoned peripheral vascular representative, shares her incredible transition from a peripheral vascular nurse to a top medical device sales expert at Shockwave. Discover how she leveraged her clinical background to drive innovation and improve patient outcomes, particularly in preventing amputations for those with peripheral arterial disease.
A version of this article was previously published on PharmaPhorum. As the demands of modern healthcare grow, new therapies are introduced at record speeds, and guidelines are quickly updated, it is key that medical education evolves to keep up. Traditional medical educationreliant on didactic presentations with limited opportunity for interactionis plagued by a range of issues, including suboptimal participation and no or poor personalisation ability.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Bristol Myers Squibb has agreed a merger with 2seventy bio in a deal worth approximately $286 million. A year ago, 2seventy decided to exclusively focus on unlocking the value of Abecma, with the goal of delivering more time for people living with multiple myeloma and maximizing value for all stakeholders, stated Chip Baird, Chief Executive Officer, 2seventy bio.
Do you remember choosing between two types of COVID tests? PCR tests were highly accurate but took several days to get results. Meanwhile, antigen-based rapid tests offered results within minutes, but were far less accurate. In this week's episode, Stewart Gandolf speaks with Martin Price , CEO of HealthTrackRx , to explore how an innovative business model, leading-edge sales strategies, and game-changing partnerships has enabled HealthTrackRx to offer and scale next-morning PCR results nationwi
Do you remember choosing between two types of COVID tests? PCR tests were highly accurate but took several days to get results. Meanwhile, antigen-based rapid tests offered results within minutes, but were far less accurate. In this week's episode, Stewart Gandolf speaks with Martin Price , CEO of HealthTrackRx , to explore how an innovative business model, leading-edge sales strategies, and game-changing partnerships has enabled HealthTrackRx to offer and scale next-morning PCR results nationwi
Neurotech Pharmaceuticals surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). Its the first therapy for this rare retinal degeneration disorder. The post Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder appeared first on MedCity News.
Struggling to stand out in medical sales? This episode is your blueprint for crafting a resume that gets noticed, even if you don’t have direct sales experience. Learn how to position your background as an asset, highlight your sales potential, and structure your resume for maximum impact. We’ll also dive into LinkedIn strategies to boost your visibility and connect with decision-makers, plus real success stories from professionals who made the leap.
Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Sales teams today need training that feels real, moves fast, and delivers measurable results. Thats why were introducing major enhancements to Quantified’s AI role play technology giving sales reps a more lifelike, adaptive, and effective way to practice their conversations. The latest updates focus on three critical areas: Faster deployment Get AI avatars up and running in less time, reducing training delays More realistic interactions Improved responsiveness and expressiveness make AI
Life is unpredictable. Its full of challenges that can hit when we least expect them. For me, one of those challenges came at the peak of my athletic career. At 19 years old, I was living my dream as a star wide receiver for Florida State University and a black-belt kickboxer. My last fight had even been televised on ESPN. But in a single, fateful moment, everything changed.
The current wave of generative AI has captured public imagination, but we must temper our expectations. While these models demonstrate impressive capabilities in processing vast amounts of medical literature and generating coherent text, they’re far from perfect. The post Fluency Isnt Intelligence in Healthcare appeared first on MedCity News.
A team of researchers in Japan have developed a novel artificial photosynthesis method that transforms waste organic compounds into valuable pharmaceuticals and energy using sunlight and water. The approach, known as artificial photosynthesis directed toward organic synthesis (APOS), represents a major step forward in sustainable chemical manufacturing.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.
Pharma-exclusive Webinar: From Clicks to Outcomes: Measuring the Impact of Your Medical Education Platform About the webinar Tired of building medical education programs that fail to deliver? Impetus Digital invites you to our free webinar on May 13 and 14 , designed specifically for life science professionals who are ready to build a medical education platform that truly engages HCPs and drives measurable results.
Explore the concept of "uncertainty fatigue" and its profound impact on employees dealing with rapid workplace transformations, global events, and economic volatility. Understand the symptoms and consequences of this growing challenge and discover six practical strategies that leaders can implement to foster resilience, reduce stress, and enhance overall well-being in the workplace.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target. The post Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy appeared first on MedCity News.
A paper published by the Drug Safety Research Unit (DSRU) in the British Journal for Clinical Pharmacology , has asserted the need for ongoing assessment of the safety and effectiveness of the Alzheimers drug lecanemab in the real-world clinical setting. The Medicines and Healthcare products Regulatory Agency (MHRA) approved the drug for use in the UK in August 2024.
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.
Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.
The Evolution of Pharma Sales: Combining AI and Social Media to Promote Brands Pharmaceutical businesses now have access to a whole new level of insights due to social media. Real-world intelligence is evident in the discussions taking place on social media. Social medias position in pharmaceutical research is further cemented by peoples growing usage of it.
On February 21, 2025 , the FDA officially determined that the shortage of semaglutide injection products has been resolved. Semaglutide is a glucagon-like peptide 1 (GLP-1) medication whose shortage has been in effect since 2022. Originally developed to treat type 2 diabetes, semaglutide and other similar GLP-1 medications have found demand in the market as weight loss medications when used together with diet and exercise to help individuals with at least one weight-related medical condition.
Healthcare organizations are starting to implement AI agents autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and reliability standards.
MSD has announced it has opened a new $1 billion vaccine manufacturing facility at its site in Durham, North Carolina, US. “Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our efforts to strengthen our production and manufacturing capabilities in the US,” commented Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.
Every March, South by Southwest takes over Austin, TX, with a conference-festival hybrid showcasing the latest in tech-driven creativity. EVERSANA INTOUCH has been there every year for more than a decade, engaging with leaders and distilling our experiences into actionable insights for our clients. At SXSW 2025, we heard loud and clear: Pharma marketers are facing the biggest challenge of our careers.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
278 
Let's personalize your content